DOCS

$24.41-0.39 (-1.57%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Doximity, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$24.41
Potential Upside
11.2%
Whystock Fair Value$27.13
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the l...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.60B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
20.51
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.44
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
24.01%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
6.63

Recent News

Insider Monkey
Mar 20, 2026

Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target

Doximity, Inc. (NYSE:DOCS) is among the 10 Best New AI Stocks to Buy. On March 18, Freedom Capital analyst Gene Mannheimer initiated coverage on Doximity, Inc. (NYSE:DOCS) with a Buy rating and a $31 price target, highlighting the company’s strong network effects, scalable business model, and above-average growth potential. The analyst emphasized that recent share price […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
The Fly
Mar 18, 2026

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 14, 2026

Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback

Why Doximity (DOCS) Is Drawing Investor Attention Now Doximity (DOCS) has been on many investors’ watchlists after a steep share price decline over the past year. This has prompted fresh questions about how its current valuation lines up with its financial profile. See our latest analysis for Doximity. At a latest share price of US$24.37, Doximity’s recent pattern includes a 44.42% 3 month share price return decline and a 61.55% 1 year total shareholder return decline. This may indicate...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

2 Software Stocks with Solid Fundamentals and 1 We Turn Down

Software is eating the world, and virtually no business is left untouched by it. This secular theme makes SaaS companies attractive investment candidates but also comes with higher valuations that cause volatility. Unfortunately, the rich prices have haunted them over the past six months as the industry has shed 22%. This drop is a far cry from the S&P 500’s 3% ascent.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
MT Newswires
Mar 9, 2026

Doximity's Early 2026 Portal Activity Points to Steady Demand, RBC Says

Doximity (DOCS) is poised to benefit from positive January and February web-traffic trends on its he

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.